Labcorp Holdings Inc.
321.10USD
-3.7600 (-1.16%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 11.9B | 12.2B | 13.0B | 14.0B | 14.7B | 15.5B |
| Q1 | 3.9B | 3.0B | 3.2B | 3.3B | 3.5B | — |
| Q2 | 2.9B | 3.0B | 3.2B | 3.5B | 3.7B | — |
| Q3 | 2.9B | 3.1B | 3.3B | 3.6B | 3.8B | — |
| Q4 | 2.9B* | 3.0B* | 3.3B* | 3.5B* | 3.7B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 13.97 | 4.77 | 8.84 | 10.46 | 18.35 | 19.82 |
| Q1 | 5.23 | 2.39 | 2.69 | 2.52 | 3.35 | — |
| Q2 | 3.87 | 2.12 | 2.43 | 2.84 | 3.64 | — |
| Q3 | 3.90 | 2.11 | 2.00 | 3.12 | 4.65 | — |
| Q4 | .831* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -1.91* |
| 1.70* |
| 1.97* |
| 4.45 |
| — |